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Recent studies show that both cellular and humoral aspects of innate immunity play
important roles during tumor progression. These interactions have traditionally been
explored in vertebrate model systems. In recent years, Drosophila has emerged as a
genetically tractable model system for studying key aspects of tumorigenesis including
proliferation, invasion, and metastasis. The absence of adaptive immunity in Drosophila
provides a unique opportunity to study the interactions between innate immune system
and cancer in different genetic contexts. In this review, I discuss recent advances made by
using Drosophila models of cancer to study the role of innate immune pathways Toll/Imd,
JNK, and JAK-STAT, microbial infection and inflammation during tumor progression.
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The interaction between the tumor and the immune system is a
complex, multi-step process in which both innate and adaptive
branches of the immune system participate (Finn, 2012). The out-
come of this antitumor response is variable and unpredictable;
it can be tumor suppressive or tumor promoting depending on
the immunogenicity and genetic composition of the tumor and
the strength of patient’s immune response (Finn, 2012). Several
recent studies report that at least some aspects of the relationship
between the immune system and cancer are also conserved in flies
(Pastor-Pareja et al., 2008; Apidianakis et al., 2009; Cordero et al.,
2010; Bangi et al., 2012): Drosophila immune system also rec-
ognizes and responds to tumors and this response can be tumor
promoting or tumor suppressive depending on the genetic com-
position of the tumor. Here, I briefly summarize studies that
use Drosophila to explore the role of the innate immune system
during tumor progression.
INFLAMMATION, TUMOR ASSOCIATED HEMOCYTES (TAHs),
AND INVASION
The first potential link between cancer and inflammation was
proposed 2000 years ago, when the Roman physician Galenos
suggested that cancers evolved from inflammatory lesions
(Trinchieri, 2012). The first experimental evidence supporting
this remarkable observation would not emerge until 1863, when
German scientist and physician Rudolf Virchow observed that
leukocytes were associated with neoplastic tissues, re-establishing
this forgotten link between cancer and inflammation (Balkwill
and Mantovani, 2001). Now, it is a well-established fact that
inflammation impacts every aspect of of tumor development and
progression (Trinchieri, 2012).
An early step in the anti-tumor response is the recruitment of
macrophages and other blood cells mediating the innate immune
response to the tumor site (Finn, 2012). These cells phagocy-
tose tumor cells and secrete inflammatory cytokines to both
maintain the innate immune response and promote and support
activation of the adaptive immune response (Finn, 2012). While
the Drosophila immune system shows evidence of some primed
responses (Kvell et al., 2007), flies lack adaptive immunity as we
know it in mammals. However, both the cellular and humoral
aspects of the innate immune response and the pathways that
mediate them are highly conserved (Hoffmann et al., 1999).
The cellular arm of the Drosophila immune response consists
of circulating blood cells called hemocytes. There are three mor-
phologically distinct types of hemocytes in Drosophila that share
a common developmental and evolutionary origin with mam-
malian blood cells (Hartenstein, 2006). Plasmatocytes are the
most common hemocyte type in Drosophila, comprising more
than 95% of all hemocytes. Plasmatocytes resemble mammalian
phagocytes and like macrophages, they are recruited to sites of
infections or wounds to phagocytose apoptotic cells, invading
microbes, and other foreign bodies (Tepass et al., 1994; Franc
et al., 1999; Elrod-Erickson et al., 2000). Like their mammalian
counterparts, Drosophila hemocytes are also recruited to epithe-
lial tumors (Pastor-Pareja et al., 2008). Epithelial tumors are
often established in Drosophila by generating patches of epithe-
lial cells (clones) mutant for apical/basal polarity genes such as
scrib (scr), lethal giant larvae (lgl), or discs large (dlg) while also
expressing the oncogenic form of Drosophila dRas1 (e.g., scrib−/−
dRas1V12) (Pastor-Pareja et al., 2008; Gonzalez, 2013). Cells
mutant for apical/basal polarity genes alone are quickly elimi-
nated from the epithelium by apoptosis in a JNK dependent man-
ner (Rudrapatna et al., 2012). However, co-expressing dRas1V12
in these polarity-defective cells leads to invasive tumors as JNK
pathway activation in these tumors promotes MMP expression,
basement membrane degradation and invasion instead of apop-
tosis (Brumby and Richardson, 2003; Pagliarini and Xu, 2003).
Using a scrib−/− dRas1V12tumor model, Pastor-Pareja and
collegues showed that hemocytes infiltrate epithelial tumors
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in Drosophila (Pastor-Pareja et al., 2008). Tumor bearing ani-
mals also show increased numbers of circulating hemocytes and
enlarged lymph glands as a result of increased hemocyte pro-
liferation. Interestingly, this anti-tumor response is remarkably
similar to the immune response to experimentally induced asep-
tic wounds, consistent with the idea that tumors are like wounds
that never heal (Dvorak, 1986).
The mechanism by which hemocytes are recruited to tumors
is not clear. However, Tumor Associated Hemocytes (TAHs)
are preferentially found in the regions of the tumor where the
basement membrane is disrupted (Pastor-Pareja et al., 2008).
Basement membrane disruption in the absence of tumors by
overexpression of MMP2 is sufficient to induce hemocyte recruit-
ment but not proliferation, indicating that basement membrane
break-down is only one of the signals mediating this immune
response.
Local activation of JNK signaling in the tumor cells is criti-
cal for the maintenance of the anti-tumor response (Pastor-Pareja
et al., 2008). JNK signaling promotes the secretion of JAK-STAT
activating cytokines (Upd ligands) from the tumor; this initiates a
positive feedback loop that activates upd expression in hemocytes
and the fat body (also the site of antimicrobial peptide expression
and release in response to infection). The increased JAK-STAT
pathway activity in the hemocytes is required to induce hemocyte
proliferation in response to tumors.
Tumor Necrosis Factor (TNF) signaling is another critical
component of the inflammatory response activated in response
to microbial infection, tissue damage and malignant cells (Waters
et al., 2013a). While both tumor suppressive and tumor pro-
moting roles for this pathway have been well established, the
molecular mechanisms mediating these different responses are
less clear (Waters et al., 2013b). Drosophila has a highly conserved
but simplified TNF pathway with a single TNF ligand called Eiger
(Egr) (Igaki et al., 2002; Moreno et al., 2002). Removal of scrib−/−
or lgl−/− cells from the epithelium also requires TNF/Eiger indi-
cating a conserved role for TNF signaling as a tumor suppressor
pathway in Drosophila within these genetic contexts (Igaki et al.,
2009; Cordero et al., 2010).
Cordero and collegues showed that hemocyte attachment and
infiltration of tumors provoke tumor cells to induce high levels
of egr expression in TAHs (Cordero et al., 2010). By transfusing
hemocytes into tumor bearing larvae with egr mutant or wild-
type hemocytes, Cordero and collegues show that egr expression
in TAHs is required to induce JNK signaling and MMP expres-
sion in tumor cells and that these defects can be partially rescued
by transfusing animals with egr+/+ hemocytes. Most importantly,
removing egr from TAH’s has drastically different consequences
on tumors with different genotypes: scrib−/− tumors cannot be
eliminated from the tissue without egr+/+ hemocytes, indicat-
ing a tumor suppressive role for TAHs and TNF signaling in this
genetic context (Figures 1A,C). In contrast, Egr signaling from
the TAHs is essential for scrib−/− dRas1V12 cells to become inva-
sive tumors (Figures 1B,C) indicating a tumor promoting role for
this pathway in this genetic context.
Activation of JNK signaling and induction of MMP1 expres-
sion are a part of the normal immune response to facilitate
delamination of abnormal cells from the epithelium and promote
further infiltration of the wound or infection by hemocytes. As
both JNK and TNF pathways are strong inducers of cell death,
these MMP expressing cells are normally quickly eliminated by
apoptosis to ensure tissue integrity. However, these studies suggest
that if these JNK/MMP1 positive tumor cells persist long enough
in the tissue, for instance as a result of additional mutations that
prevent apoptosis, they can further promote degradation of the
basement membrane and infiltration by additional TAHs. This
in turn leads to a positive feedback loop that increases the num-
ber of JNK/MMP positive cells within the tumor and thereby its
metastatic potential (Figures 1A–C).
Aspects of bacterial infection can also be studied by
directly expressing pathogen-derived proteins in host tissues. For
instance, Drosophila models of H. pylori infection have been
generated by expressing the H. pylori virulence factor CagA in
Drosophila tissues (Botham et al., 2008; Wandler and Guillemin,
2012). Certain virulent strains of H. pylori possess a secretion
system that allows them to directly inject the CagA protein
into gastric epithelial cells and can promote the development
of gastric carcinoma in a small percentage of infected indi-
viduals (Peek and Blaser, 2002; Hatakeyama, 2008; Wroblewski
et al., 2010). Wandler and Guillemin showed that CagA expres-
sion in discrete domains in the Drosophila wing disc epithe-
lium leads to the activation of apoptosis in a subset of CagA
expressing cells in a JNK signaling dependent fashion (Wandler
and Guillemin, 2012). Interestingly, loss of egr function in the
whole animal increased the number of apoptotic CagA express-
ing cells, but not when egr was only reduced in CagA expressing
cells. This suggests a non-cell-autonomous role for Egr in apop-
totic cell clearance. The authors propose a model whereby loss
of Egr from the neighboring wildtype epithelial cells mediate
elimination of apoptotic CagA expressing cells from the epithe-
lium. CagA expression also synergized with oncogenic Ras to
facilitate JNK mediated tumor progression and invasion, how-
ever, the role of Egr in this context has not been investigated.
Furthermore, potential roles for the core immune signaling path-
ways and the cellular immune response in this process remain
unexplored possibilities. It will be interesting to see if hemocytes
also associate with tumors in this paradigm and whether simi-
lar pro-tumor and anti-tumor roles for Egr/TNF signaling can be
elucidated.
TOLL/Imd SIGNALING, MICROBIAL INFECTION, AND
CANCER
Recognition or pathogen and damage associated molecular pat-
terns by the immune system is a key component of mounting
an effective host defense. In Drosophila, this innate immune
response is mediated by two pathways: Recognition of Gram
positive bacteria and fungi depends on secreted factors that reg-
ulate the processing and activation of the Toll receptor ligand
Spatzle (Spz) (Lemaitre et al., 1996). Subsequent activation of
the Toll pathway leads to the expression and secretion of antimi-
crobial peptides (AMPs) mediated by NFκB related molecules
Dorsal and Dif (Valanne et al., 2011). On the other hand, Gram
negative bacteria are recognized by pattern recognition recep-
tors called PGRPs, ultimately leading to activation of another
NFκB related molecule called Relish as well as JNK pathway in
Frontiers in Cellular and Infection Microbiology www.frontiersin.org December 2013 | Volume 3 | Article 103 | 2
Bangi Anti-tumor immune responses in Drosophila
FIGURE 1 | Summary of tumor cell-immune system interactions in
Drosophila. (A) Clones of cells defective for cell polarity genes such as
scrib (green) generated in the context of a wild type tissue (yellow) are
rapidly eliminated from the epithelium with the help of tumor associated
hemocytes (TAHs, purple). (B) This antitumor immune response is
subverted in scrib−/− dRas1V12 cells, leading to the establishment of an
invasive tumor. (C) Reciprocal interactions between tumor cells (green)
TAHs (purple), and fat body (gray) result in both local and systemic release
of inflammatory cytokines in a positive feedback loop. (D) Microbial
infection synergizes with dRas1V12 to induce activation of JNK signaling
(blue nuclei) and Mmp expression (red) in transformed hindgut epithelial
cells, leading to migration and dissemination. (E) Microbial infection
induces apoptosis of differentiated enterocytes (yellow), and synergizes
with with dRas1V12 to induce hyperplastic ISC/EB-like tumors. BM,
Basement Membrane; Mmp, Matrix Metalloprotease; ISC, Intestinal Stem
Cell; EB, Enteroblast.
an Imd dependent fashion (Choe et al., 2002; Ramet et al., 2002;
Kallio et al., 2005). In mammals, Toll Related Receptor (TLR)
signaling is activated by direct binding of pathogen associated
molecules, leading to NFκB-mediated induction of AMP expres-
sion (Takeuchi and Akira, 2010). In addition, pathogen associated
peptidoglycan fragments are recognized by NOD-like Receptors
(NLRs), which leads to activation of NFκB and JNK pathways
(Lavelle et al., 2010). Even though there are some differences
in the activation mechanisms of these pathways, most of the
downstream pathway components and their roles are highly con-
served between mammals and Drosophila (see reference 30 for an
in-depth comparative analysis).
Stimulation of innate immune responses by microbial com-
ponents can also modulate migratory potential of epithelial cells
(Wang et al., 2003; Merrell et al., 2006) and recent identifica-
tion of functionally active TLRs in several tumor cell lines point
to important roles for TLR signaling in epithelial tumor pro-
gression and metastasis (Huang et al., 2005, 2008; Kelly et al.,
2006; Rakoff-Nahoum and Medzhitov, 2009). In recent years sev-
eral groups took advantage of the high degree of conservation
of core immune signaling pathways in Drosophila to explore
the relationship between innate immune responses and tumor
progression.
The gastrointestinal tract is a prominent component of
both mammalian and Drosophila immune systems. The intesti-
nal epithelium expresses several TLRs and studies both in
murine models and in Drosophila reveal that intestinal epithe-
lial cells respond to microbial infection by secreting AMPs, a
Toll/Imd/TLR signaling mediated process (O’Neil et al., 1999;
Apidianakis et al., 2005). Interestingly, chronic activation of the
immune response is thought to facilitate intestinal tumorige-
nesis in genetically predisposed individuals (Pasparakis, 2008;
Secher et al., 2010), again suggesting a pro-tumorigenic role
for Toll/Imd/TLR signaling in the intestine. We found that
acute activation of the Imd pathway in response to micro-
bial infection interacts with pre-existing oncogenic mutations
to promote tumorigenesis in a dRas1V12 induced model of
colon cancer in Drosophila (Bangi et al., 2012). When targeted
to the hindgut epithelium—the functional equivalent of the
mammalian colon—dRas1V12 activates JNK signaling and MMP
expression in a subset of the hindgut epithelial cells. These trans-
formed cells eventually migrate out of the epithelium to colonize
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distant sites within the animal. While JNK/MMP positive cells do
not migrate themselves, both JNK signaling andMMP expression
is necessary for the dissemination phenotype. Microbial infection
of these animals using a previously established infection paradigm
by oral feeding of the Gram negative bacterium Pseudomonas
aeruginosa (Apidianakis and Rahme, 2009, 2011) leads to a sig-
nificant enhancement of dRas1V12 induced dissemination in an
Imd dependent fashion. Microbial infection in this case increases
the metastatic potential of the tumor by increasing the number
of JNK/MMP1 positive cells, thereby further compromising the
integrity of the tissue and facilitating the migration of dRas1V12
transformed cells (Figure 1D).
By contrast in the midgut, microbial infection synergizes
with dRas1V12 to induce intestinal hyperplasia but not inva-
sion or dissemination; in this model, dRas1V12 was targeted
to intestinal stem cells (ISCs) and undifferentiated enterob-
lasts (EBs), the immediate progeny of ISCs (Apidianakis and
Rahme, 2009; Pitsouli et al., 2009) (Figure 1E). Hyperplasia is
driven by bacteria-induced death of differentiated midgut cells.
Curiously, JNK induced secretionof JAK-STAT inducing cytokines
(Upd-1, -2, -3) by the dying midgut cells is known to be a key
mediator of tissue regeneration (Jiang et al., 2009), reminiscent of
the positive feedback loop created between TAHs and tumor cells
in the imaginal disc tumor models discussed above (Pastor-Pareja
et al., 2008). Adult hemocytes have been reported to respond to
microbial infection by phagocytosing invading pathogens in mul-
tiple infection paradigms (Elrod-Erickson et al., 2000; Kocks et al.,
2005; Nehme et al., 2007). However, there is no evidence that they
infiltrate the adult gut as part of the immune response andwhether
they contribute to hyperplasia and dissemination phenotypes in
these intestinal cancer models have not been investigated.
ANTIVIRAL IMMUNITY AND CANCER
In addition to bacterial and fungal infection paradigms, several
Drosophila models of viral infection also exist; these include
models that use natural viruses that infect Drosophila as well
as several viruses that cause disease in humans and those that
directly express various viral proteins in Drosophila tissues (Bier
and Guichard, 2012; Merkling and van Rij, 2013). The major
immune defense against viral infection in insects is the RNA
interference pathway, however, several recent reports indicate
possible roles for the evolutionarily conserved core immune sig-
naling pathways Toll, Imd, and JAK-STAT in antiviral immunity
(Dostert et al., 2005; Zambon et al., 2005; Costa et al., 2009).
It would be interesting to combine these viral infection models
with available Drosophila cancer models to explore interactions
between viral infection, antiviral immunity and cancer.
DROSOPHILA OFFERS NEW TOOLS TO EXPLORE LINKS
BETWEEN IMMUNOLOGY AND CANCER
The presence of an antitumor immune response in Drosophila
opens up new avenues of research in the field of tumor immunol-
ogy. The absence of an adaptive immune response precludes
modeling certain aspects of immune response. However, signaling
pathways that mediate the interactions between tumor cells and
the innate immune system (JNK, JAK-STAT, TNF, Toll/Imd/TLR)
as well as the way these pathways interact with each other are
highly conserved in flies.
The sophisticated genetic tools available in Drosophila can be
used for genetic dissection of conserved aspects of the anti-tumor
immune response. For instance, multiple independent targeted
and inducible expression systems are available in Drosophila (del
Valle Rodriguez et al., 2012), making it possible to separately
label and genetically manipulate tumor cells and cells of the
immune system. An increasing number of genetically complex
tumormodels are being reported in Drosophila (Gonzalez, 2013).
For instance, 30 multigenic models of colon cancer in the adult
Drosophila gut have recently been generated and characterized in
our laboratory (Bangi et. al., in review). These models allow us
to explore the mechanisms by which the innate immune system
reacts to tumors with different genetic compositions.
Lastly, Drosophila is emerging as a useful platform for can-
cer drug discovery: flies provide a high degree of conservation of
cancer relevant pathways as well as appropriate sensitivity to com-
pounds targeting these pathways (Bangi et al., 2011; Gonzalez,
2013). Compound screens in Drosophila using organismal lethal-
ity or other complex phenotypic read outs of cancer are revealing
new anti-cancer agents with promising activity in mammalian
models (Dar et al., 2012). With these tools, Drosophila can be
useful both as a genetic model system for tumor immunology but
also as a drug discovery platform to screen for compounds that
target the immune system and its interactions with tumor cells.
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